{
    "code": 0,
    "data": [
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED ON 31.12.2025",
            "news_body": "Unaudited Financial Results of the Company for the Quarter and Nine Months ended on 31.12.2025.",
            "news_id": "1bfd8813-481d-4e24-b483-dd87944aa7f1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56515797-ca90-4745-a79a-b2e953f9a644.pdf",
            "news_date": "2026-02-12 11:38:22",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED ON 31.12.2025",
            "news_body": "Unaudited Financial Results of the Company for the Quarter and Nine Months ended on 31.12.2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56515797-ca90-4745-a79a-b2e953f9a644.pdf",
            "news_date": "2026-02-12 11:38:22"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for OUTCOME OF BOARD MEETING",
            "news_body": "Outcome of the meeting held today",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b103df1f-f202-48da-9bdf-89a89aa73763.pdf",
            "news_date": "2026-02-12 11:29:57"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Third Quarter And Nine Months Ended 31St December 2025.",
            "news_body": "Lincoln Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve unaudited Financial Results (Standalone And Consolidated) Of The Company For The Third Quarter And Nine Months Ended 31st December 2025 And Other Business if any.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11ccdcc8-0a0b-49e9-aa1e-81edee104cc9.pdf",
            "news_date": "2026-02-04 12:07:58"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Update on Credit Rating.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e655faf1-8685-4e3b-8db5-29578c681106.pdf",
            "news_date": "2026-01-10 16:46:42"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Pursuant to provision of Regulation 74(5) of SEBI (Depository and Participants) Regulation 2018 we hereby submit the confirmation certificate received from MUFG Intime India Private Limited Registrar and Share Transfer Agent (RTA) for the Quarter ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bb1e5ca8-2f52-4d4e-afa0-1e46fc1a94f9.pdf",
            "news_date": "2026-01-06 18:48:44"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85e3ce05-0e4f-4d58-a476-a0d7473d0e40.pdf",
            "news_date": "2025-12-24 15:37:49"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 we enclosed herewith the copies of newspaper intimation with respect to un-audited financial results for the quarter and half year ended on 30.09.2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=496d6fcb-fc5c-4aae-ae05-da9fdf0514df.pdf",
            "news_date": "2025-11-14 14:38:31"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2025",
            "news_body": "UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2025",
            "news_id": "3575f9ea-2307-4d78-8ca2-4e1a7b649403",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12d9b317-3026-42f6-a947-5951468b0e3a.pdf",
            "news_date": "2025-11-13 12:33:12",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2025",
            "news_body": "UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12d9b317-3026-42f6-a947-5951468b0e3a.pdf",
            "news_date": "2025-11-13 12:33:12"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2025",
            "news_body": "UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55df7300-b590-4f07-a674-4bdebbdce55c.pdf",
            "news_date": "2025-11-13 12:28:04"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Considering And Approving The Standalone And Consolidated Unaudited Financial Results Of The Company For The Quarter And Half Year Ended 30.09.2025.",
            "news_body": "Lincoln Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve Standalone and Consolidated Unaudited Financial Results of the Company for the Quarter and Half Year ended 30.09.2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef4a3c1d-4d32-4164-907d-d2c4dbd16b68.pdf",
            "news_date": "2025-11-05 15:04:10"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "AGM",
            "caption": "Minutes Of 31St Annual General Meeting Of The Company.",
            "news_body": "With reference to the above please find enclosed herewith the Minutes of 31st Annual General Meeting of the Company held at 11:00 A.M on Tuesday  the 30th September 2025 through Video Conferencing (\"VC\")/ Other Audio-Video Visual Means (OVAM) to seek the approval of the members of the Company on resolutions set out in the Notice convening meeting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80f52cba-3f71-4b49-a79c-6f27fb380c5f.pdf",
            "news_date": "2025-10-28 12:53:48"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement regarding the opening of special window for re-lodgement of transfer requests of physical shares.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dec72650-0a74-4bcc-84fd-1c7ce1782585.pdf",
            "news_date": "2025-10-08 12:57:57"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate from RTA for the Quarter ended September 30 2025 under Regulation 74(5) of SEBI (DP) Regulations 2018.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5cae5823-d007-4075-a41d-f415aa244feb.pdf",
            "news_date": "2025-10-07 13:50:06"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Submission of Scrutinizers Report of 31st AGM of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=95dbe97c-d6be-408b-9c10-bb80322caf30.pdf",
            "news_date": "2025-10-03 11:33:44"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "AGM",
            "caption": "Submission Of E-Voting Results Of 31St AGM Along With The Scrutinizer Report As Per Regulation 44 Of SEBI (LODR) Regulation 2015.\r\n",
            "news_body": "Submission of E-Voting Results of 31st AGM along with the Scrutinizer Report as per Regulation 44 of SEBI (LODR) Regulation 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db152868-1973-486c-a308-e153fcef9122.pdf",
            "news_date": "2025-10-03 11:21:57"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Submission of Proceedings of the 31st Annual General Meeting of the Company held today.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=062a1323-2a88-4b64-b51c-55aa595598b3.pdf",
            "news_date": "2025-09-30 17:29:51"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Closure of Trading Window.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40f1724a-4fd9-438e-9abf-15600547cc09.pdf",
            "news_date": "2025-09-23 15:10:51"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication for Notice of 31st Annual General Meeting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8e10eb3-f367-473e-81fd-635fe729b9b3.pdf",
            "news_date": "2025-09-08 14:38:24"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "General Updates",
            "news_body": "Intimation regarding dispatch of physical communication to the Shareholders who have not registered their email address.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62e1ac9c-276f-4922-a256-8d258d5cb054.pdf",
            "news_date": "2025-09-06 16:16:52"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Pursuant to Regulation 34(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (\"the SEBI Listing Regulations\") we are submitting herewith the Annual Report of the Company along with the Notice of 31st Annual General Meeting (\"AGM\") for the Financial Year 2024-2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2847bd06-c591-4ab0-bfe8-170272ee6beb.pdf",
            "news_date": "2025-09-06 15:13:32"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": " Notice Of 31St Annual General Meeting Of The Company.",
            "news_body": "31st Annual General Meeting (\"AGM\") of the Members of the Company will be held on Tuesday 30th September 2025 at 11:00 A.M (IST) through Video Conferencing (\"VC\")/Other Audio-Visual Means (\"OVAM\") in accordance with relevant circulars issued by Ministry of Corporate Affairs and Security and Exchange Board of India. We hereby enclose the Notice of 31st Annual General Meeting of the Company which is being sent to the members through electronic mode.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02978ea5-d4ed-4361-846a-1c22a5565ad0.pdf",
            "news_date": "2025-09-06 14:01:19"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "We wish to inform you that Mr. Raja Karunanidhi Nagarajan has been appointed as \"Senior General Manager- Research & Development\" (Senior Management Personnel) of the Company w.e.f 29-08-2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c8eb3863-f984-4d24-8a9c-95d9aae249f9.pdf",
            "news_date": "2025-08-29 17:08:08"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Intimation Of Book Closure And Record Date For The Purpose Of 31St Annual General Meeting And Final Dividend For The Financial Year 2024-25.",
            "news_body": "The Intimation of Book Closure and Record Date is as enclosed.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97d96236-f004-4c7e-bd7f-909fa7d31519.pdf",
            "news_date": "2025-08-29 11:27:33"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Intimation",
            "descriptor": "Book Closure",
            "caption": "Corporate Action-Fixes Book Closure For Determining The Dividend If Approved At The AGM",
            "news_body": "Pursuant to the Regulation 42 of SEBI (LODR) Regulations 2015  we would like to inform you that the 31st Annual General Meeting of the Company is scheduled to be held on Tuesday September 30 2025 at 11:00 A.M (IST) through Video Conferencing (\"VC\")/Other Audio-Visual Means (\"OVAM\").",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e0eba86e-892c-4507-a091-6ac483840f1d.pdf",
            "news_date": "2025-08-29 10:49:42"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement regarding the 31st Annual General Meeting of the Company to be held on Tuesday September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b8cc22c7-71a9-4ba8-9739-a7b026a575ef.pdf",
            "news_date": "2025-08-26 15:19:53"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "We enclosed herewith the copies of newspaper intimation with respect to the Unaudited (Standalone & Consolidated) Financial Results of the Company for the Quarter ended on 30.06.2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a462bae2-1b6d-415d-b3c3-bf27899e0cf2.pdf",
            "news_date": "2025-08-08 11:02:37"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "Meeting Updates",
            "caption": "Appointment Of Secretarial Auditor",
            "news_body": "Appointment of Secretarial Auditors.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc6bb0c6-8e0d-4515-8001-9b99c83822b9.pdf",
            "news_date": "2025-08-07 13:06:57"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Re-appointment of Managing Director and Whole-time Directors of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2d2fb654-2784-4677-9e29-534906293059.pdf",
            "news_date": "2025-08-07 13:04:29"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "UN AUDITED FINANCIAL RESULTS FOR QUARTER ENDED ON 30-JUNE-2025",
            "news_body": "UN AUDITED FINANCIAL RESULTS FOR QUARTER ENDED ON 30-JUNE-2025.",
            "news_id": "0b609264-bfff-40e9-a499-0218f430462e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9938645-4db6-43ff-97e0-ce7b4619dcc8.pdf",
            "news_date": "2025-08-07 12:55:57",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "UN AUDITED FINANCIAL RESULTS FOR QUARTER ENDED ON 30-JUNE-2025",
            "news_body": "UN AUDITED FINANCIAL RESULTS FOR QUARTER ENDED ON 30-JUNE-2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9938645-4db6-43ff-97e0-ce7b4619dcc8.pdf",
            "news_date": "2025-08-07 12:55:57"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED ON 30-JUNE-2025",
            "news_body": "UN-AUDITED FINANCIAL RESULTS OF THE COMPANY FOR THE QUARTER ENDED ON 30-JUNE-2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=15a622b0-3e59-4683-b447-949b83628224.pdf",
            "news_date": "2025-08-07 12:51:05"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Considering And Approving The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30 2025.",
            "news_body": "Lincoln Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2025 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0ad98a9-d6eb-4e3a-a0f9-708b54a7bb22.pdf",
            "news_date": "2025-07-28 16:43:38"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Intimation of Change in SMP.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb3bc0d0-4deb-4014-8fd1-1a95515d5abb.pdf",
            "news_date": "2025-07-08 17:01:53"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "We hereby submit the confirmation certificate as received from M/S MUFG Intime India Private Limited Registrar and Share Transfer Agent for the Quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a0d37a2-9190-4628-b14c-fa1e4c95bdd2.pdf",
            "news_date": "2025-07-07 15:01:51"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Updates Pursuant To Regulation 30 Of The SEBI (LODR) Regulations 2015.",
            "news_body": "Updated pursuant to Regulation 30 of the SEBI (LODR) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cdd54e7f-28eb-444f-bccb-04ebf21752fb.pdf",
            "news_date": "2025-07-02 11:38:27"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Trading Window Closure for the Quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c958945-3120-47c9-9b14-d616abeed6ae.pdf",
            "news_date": "2025-06-24 14:43:27"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "We enclosed herewith the copies of published newspaper advertisement with respect to Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dcdc2018-28b7-442e-aee1-1eced5183e9a.pdf",
            "news_date": "2025-05-23 12:35:25"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Outcome",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board approves Dividend",
            "news_body": "Recommended a Final Dividend of Rs.  1.80/- (i.e 18%) per equity shares of face value 10/- each for the Financial year Ended 31st March 2025 subject to approval of the members at the ensuing A.G.M of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7918d9b5-337e-472c-ab4c-67d16aa8fdeb.pdf",
            "news_date": "2025-05-22 12:42:52"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended 31St March 2025\r\n",
            "news_body": "Audited Financial Results for the Quarter and Year Ended 31st March 2025",
            "news_id": "1be88f28-e74b-4723-9e53-508bffbc3462",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9043464d-4b90-421e-8b38-f8414f6a5599.pdf",
            "news_date": "2025-05-22 12:36:35",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended 31St March 2025\r\n",
            "news_body": "Audited Financial Results for the Quarter and Year Ended 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9043464d-4b90-421e-8b38-f8414f6a5599.pdf",
            "news_date": "2025-05-22 12:36:35"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended 31St March 2025",
            "news_body": "Outcome of Board Meeting for Audited Financial Results for the Quarter and Year Ended 31st March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1cc85454-dc41-42de-8565-661aafdaa59a.pdf",
            "news_date": "2025-05-22 12:30:33"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Annual Secretarial Compliance Report for the Financial Year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be267f7b-b778-4684-b57b-bdcd48312f76.pdf",
            "news_date": "2025-05-17 16:04:47"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Intimation",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board to consider Dividend",
            "news_body": "Meeting of the Board of Directors is scheduled to be held on May 22 2025 to consider and approve Audited Financial Results of the Company and recommendation of Dividend on equity shares of the Company if any.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cdd35452-3257-4622-af95-6ae8a374b5e9.pdf",
            "news_date": "2025-05-15 11:02:35"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Consideration Of Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Year Ended On March 31 2025.",
            "news_body": "Lincoln Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2025 inter alia to consider and approve  Audited (standalone and consolidated) financial results of the Company for the quarter and year ended on March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c831e963-3617-44c4-a6de-c20d7e8aa86a.pdf",
            "news_date": "2025-05-15 10:57:15"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Compliance",
            "descriptor": "Format of the Annual Disclosure to be made by an entity identified as a LC : Annexure B2",
            "caption": "Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2",
            "news_body": "<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px>    <tr>       <td><b>Sr. No.</b></td>       <td><b>Particulars</b></td>       <td><b>Details</b></td>    </tr>    <tr>       <td>1</td>       <td>Name of Company</td>       <td>Lincoln Pharmaceuticals Ltd</td>    </tr>    <tr>       <td>2</td>       <td>CIN NO.</td>       <td>L24230GJ1995PLC024288</td>    </tr>    <tr>       <td>3</td>       <td>Report filed for FY</td>       <td>2024-2025</td>    </tr>       <tr><td colspan=3>Details of the Current block (all figures in Rs crore):</td><tr> <tr>       <td>4</td>       <td>2 - year block period (Specify financial years)* </td>       <td>2024-25 2025-26</td>    </tr>    <tr>    <tr>       <td>5</td>       <td>Incremental borrowing done in FY (T)(a) </td>       <td>0.00</td>    </tr>    <tr>       <td>6</td>       <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td>       <td>0.00</td>    </tr>    <tr>       <td>7</td>       <td>Actual borrowing done through debt securities in FY (T)(c)</td>       <td>0.00</td>    </tr>       <tr>       <td>8</td>       <td> Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d)</td>       <td>0</td>    </tr>  <tr> <td>8</td><td>Quantum of (d) which has been met from (c)(e)*</td>       <td>0</td>    </tr><tr> <td>9</td><td> Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}*</td>       <td>0</td>    </tr> </table> <br/><br/><table><tr><td colspan=2><b>Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>2024-252025-26</td></tr> <tr><td>Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div>     <br/><br/><br/>    <table><tr><td>Name of the Company Secretary :-</td><td>TRUSHA SHAH</td></tr><tr><td>Designation :-</td><td>COMPANY SECRETARY AND COMPLIANCE OFFICER</td></tr>    <tr><td>Name of the Chief Financial Officer :- </td><td>DARSHIT SHAH</td></tr>    <tr><td>Designation : -</td><td>CHIEF FINANCIAL OFFICER</td></tr></table><div> <br/> Date: 09/05/2025<br/><br/></div>",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83e7aaf8-ec60-4fce-a838-57938df4c685.pdf",
            "news_date": "2025-05-09 11:43:44"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Copies of Newspaper Advertisement as required under Rule 6 of IEPF Authority (Accounting Audit Transfer and Refund) Rules 2016 and amendments thereof.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8af3f442-c55f-4e02-8ea3-2313a5b08313.pdf",
            "news_date": "2025-05-08 14:59:01"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Compliance",
            "descriptor": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ",
            "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
            "news_body": "  <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Lincoln Pharmaceuticals Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24230GJ1995PLC024288</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table>  <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: TRUSHA SHAH <br/>  Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: TRUSHASHAH@LINCOLNPHARMA.COM</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: DARSHIT SHAH <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: DARSHIT@LINCOLNPHARMA.COM</div> </div> <div> <br/> Date: 23/04/2025<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8015acee-105c-4412-a12a-eb52848552dc.pdf",
            "news_date": "2025-04-23 15:47:30"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Change In Email And Website Address Of MUFG Intime India Private Limited Registrar And Share Transfer Agent (RTA) Of The Company",
            "news_body": "Based on the intimation received from RTA we would like to inform that the Email Address and Web Address of RTA have been updated as detailed in the enclosed disclosure. The Address telephone no. of the RTA continue to remain the same.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3cf7771b-6eea-4770-a31d-9362d9fb4d7f.pdf",
            "news_date": "2025-04-18 12:43:05"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Pursuant to provision of Regulation 74(5) of SEBI (Depository and Participant) Regulations 2018 we hereby submit the confirmation certificate as received from M/S. MUFG Intime India Private Limited Register and Share Transfer Agent (RTA) for the Quarter ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92685d5d-5737-4f0e-9b60-c1ee6c03a08c.pdf",
            "news_date": "2025-04-05 12:57:38"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015.",
            "news_body": "Dissemination of cautionary letter/mail dated 28.03.2025 received from National Stock Exchange of India Limited and BSE Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e2582af-9618-44f2-99bc-4e2fd0ebe89c.pdf",
            "news_date": "2025-03-28 18:07:58"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Trading Window Closure for the Quarter and Year ended March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=193c011b-49e1-4af6-90cf-62db88c8d6e6.pdf",
            "news_date": "2025-03-26 14:35:01"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement with respect to un-audited financial results (Standalone & Consolidated) for the Quarter & Nine Months ended December 31 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d0c3a10-793f-41ca-ab58-d187d5f835d2.pdf",
            "news_date": "2025-02-14 11:58:40"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Financial)",
            "caption": "Integrated Filing (Financial)",
            "news_body": "Integrated Filing (Financials) for the Quarter and Nine Months ended 31st December 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4fd5b12-b8b3-4511-8826-234ef9d71221.pdf",
            "news_date": "2025-02-13 13:09:51"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "UN AUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED ON 31.12.2024\r\n",
            "news_body": "UN AUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTH ENDED ON 31.12.2024\r\n",
            "news_id": "0b4f205d-9972-4e25-a1f4-566786b7781e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=58414f1a-44fd-424b-ba32-557aa08b8ba3.pdf",
            "news_date": "2025-02-13 12:21:13",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "UN AUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED ON 31.12.2024\r\n",
            "news_body": "UN AUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTH ENDED ON 31.12.2024\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=58414f1a-44fd-424b-ba32-557aa08b8ba3.pdf",
            "news_date": "2025-02-13 12:21:13"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for OUTCOME OF THE BOARD MEETING",
            "news_body": "UN AUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED ON 31.12.2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a450687b-eb2d-4b34-83c9-66e795bc8073.pdf",
            "news_date": "2025-02-13 12:16:33"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Third Quarter And Nine Months Ended 31St December 2024.",
            "news_body": "LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 inter alia to consider and approve unaudited Financial Results (Standalone And Consolidated) Of The Company For The Third Quarter And Nine Months Ended 31st December 2024 And Other Business if any.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76fbd9ec-26aa-4d0f-a663-e25f1fe7eb48.pdf",
            "news_date": "2025-02-05 11:16:10"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Pursuant to provision of Regulation 74(5) of SEBI (Depository and Participants) Regulations 2018  we hereby submit the confirmation certificate received from MUFG Intime India Private Limited Registrar and Share Transfer Agent (RTA) for the Quarter ended December 31 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=569ee7a2-b4b9-4682-af74-182ea402ebcc.pdf",
            "news_date": "2025-01-07 12:21:59"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Change Of Name Of Registrar And Share Transfer Agent (RTA) Of The Company ",
            "news_body": "Please find enclosed intimation of change of name of Registrar and Share Transfer Agent (RTA) of the Company as per Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d21feed5-e9e6-4cf6-97b3-6558d9cf41de.pdf",
            "news_date": "2025-01-03 12:51:47"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "Clarification On Volume/Price Movement Sought By BSE Limited",
            "news_body": "Clarification on Volume/Price movement in the recent past.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3710159-36f8-4837-9fea-c74ba9d064fd.pdf",
            "news_date": "2024-12-06 17:08:20"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Company Update",
            "descriptor": "Clarification",
            "caption": "Clarification sought from Lincoln Pharmaceuticals Ltd",
            "news_body": "The Exchange has sought clarification from Lincoln Pharmaceuticals Ltd on December 6, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2024-12-06 17:04:30"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Pursuant to Regulation 47 of SEBI (LODR) Regulations, 2015, we enclosed herewith the copies of newspaper intimation with respect to un-audited financial results for the quarter and half year ended on 30.09.2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5e01e3bc-98fb-4ba5-8620-dcd732971eed.pdf",
            "news_date": "2024-11-15 11:08:12"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2024",
            "news_body": "UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2024",
            "news_id": "3fa3c40f-ee77-495b-8929-bcc94ede9292",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=126956bc-f771-4bd2-b4fa-302a9eca98fa.pdf",
            "news_date": "2024-11-14 12:21:58",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2024",
            "news_body": "UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=126956bc-f771-4bd2-b4fa-302a9eca98fa.pdf",
            "news_date": "2024-11-14 12:21:58"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for OUTCOME OF BOARD MEETING",
            "news_body": "UN-AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF YEAR ENDED 30.09.2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c723356-22ac-4f39-92b8-8bb976df35cf.pdf",
            "news_date": "2024-11-14 12:16:41"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Consider And Approve The Un-Audited Financial Results For The Quarter Ended 30.09.2024.",
            "news_body": "LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 ,inter alia, to consider and approve un-audited financial results (standalone and consolidated) of the Company for the quarter and half year ended on September 30, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=814418e6-5cc6-4497-9701-111b4966d7fc.pdf",
            "news_date": "2024-11-05 11:19:06"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Minutes Of 30Th Annual General Meeting Of The Company.",
            "news_body": "With reference to the above, please find enclosed herewith the Minutes of 30th Annual General Meeting of the Company held at 11:00 A.M on Monday, the 30th September, 2024 through Video Conferencing (VC)/ Other Audio Video Visual Means (OVAM) to seek the approval of members of the Company on resolutions set out in the Notice convening meeting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8cf284db-5c7e-4521-a8ab-5213113983d2.pdf",
            "news_date": "2024-10-11 14:27:03"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "Certificate from RTA for the Quarter ended September 30, 2024 under Regulation 74(5) of SEBI (DP) Regulations, 2018.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7527c353-1297-45c8-bab2-0ac010f79054.pdf",
            "news_date": "2024-10-07 11:03:57"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizer''s Report",
            "news_body": "Submission of Scrutinizers'' Report of 30th AGM of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=65526c57-d75a-4e10-953d-8986221aa083.pdf",
            "news_date": "2024-10-03 17:43:43"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Submission Of Voting Results Of 30Th A.G.M. Along With The Scrutinizer Report As Per Regulation 44 Of SEBI (LODR) Regulation 2015.",
            "news_body": "Submission of Voting Results of 30th AGM along with the Scrutinizer Report as per Regulation 44 of SEBI (LODR) Regulation, 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=199eec18-02ed-4df7-b845-b58e4139927a.pdf",
            "news_date": "2024-10-03 17:36:55"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Submission of proceedings of the 30th Annual General Meeting of the Company held today.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5bf53317-e507-4c45-9642-0cb0b42047a1.pdf",
            "news_date": "2024-09-30 18:28:08"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Closure of Trading Window.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7eed4afb-20e9-484c-8526-5a8b27c14d6d.pdf",
            "news_date": "2024-09-23 14:03:53"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "Submission of Business Responsibility and Sustainability Reporting (BRSR) for the FY 2023-2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6619aa22-7411-43a2-85d1-9b7995b4a384.pdf",
            "news_date": "2024-09-09 15:52:08"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication for Notice of 30th Annual General Meeting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61f4a400-5833-4879-900c-8f79f2c2d520.pdf",
            "news_date": "2024-09-07 15:35:28"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Pursuant to Regulation 34(1) of Securities and Exchange Board of India (Listing obligations and Disclosure Requirements) Regulations, 2015 (the SEBI Listing Regulations) , we are submitting herewith the Annual Report of the Company along with the Notice of 30th Annual General Meeting (AGM) for the Financial Year 2023-2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c67fda9c-8077-4df4-91a4-7af9d3972996.pdf",
            "news_date": "2024-09-06 12:49:50"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "AGM/EGM",
            "descriptor": "AGM",
            "caption": "Notice Of 30Th Annual General Meeting Of The Company.",
            "news_body": "30th Annual General Meeting (AGM) of the members of the Company will be held on Monday, 30th September, 2024 at 11:00 A.M (IST) through Video Conferencing (VC) / Other Audio-Visual Means (OVAM), in accordance with relevant circulars issued by Ministry of Corporate Affairs and Security and Exchange Board of India. We hereby enclose the notice of 30th Annual General Meeting of the Company which is being sent to the members through electronic mode.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f92e5a29-24fd-48a5-8cc9-fae910f38e5a.pdf",
            "news_date": "2024-09-06 12:19:49"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Corp. Action",
            "descriptor": "Book Closure",
            "caption": "Corporate Action-Fixes Book Closure For Determining The Dividend, If Approved At The AGM",
            "news_body": "Pursuant to the Regulation 42 of SEBI (LODR) Regulations, 2015 , we would like to inform you that the 30th Annual General Meeting of the Company is scheduled to be held on Monday, September 30, 2024 at 11:00 A.M (IST) through Video Conferencing (VC) / Other Audio-Visual Means (OVAM).",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb1b24af-c3f1-4b9b-ada4-1d10385fb7ca.pdf",
            "news_date": "2024-08-29 12:05:23"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement regarding the 30th Annual General Meeting of the Company to be held on Monday, September 30, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=582a7ded-6078-4011-beef-b0063e347b15.pdf",
            "news_date": "2024-08-28 14:29:43"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "We enclosed herewith the copies of newspaper intimation with respect to the unaudited (standalone & Consolidated) financial results of the Company for the quarter ended on 30.06.2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0fb0ab5e-be27-4650-815c-6b768da9b1d1.pdf",
            "news_date": "2024-08-09 11:11:38"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter Ended 30-June-2024",
            "news_body": "Un-Audited Financial Results for the Quarter Ended 30-June-2024",
            "news_id": "2bc37fe5-2da6-46d1-a660-8a9787442c47",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa9c4157-b16a-4ae1-aa07-8883654fa228.pdf",
            "news_date": "2024-08-08 12:10:18",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter Ended 30-June-2024",
            "news_body": "Un-Audited Financial Results for the Quarter Ended 30-June-2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa9c4157-b16a-4ae1-aa07-8883654fa228.pdf",
            "news_date": "2024-08-08 12:10:18"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Un-Audited Financial Results For The Quarter Ended 30-June-2024",
            "news_body": "Out come of Un-Audited Financial Results for the Quarter Ended 30-June-2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=95e81d51-990f-4d45-9e8f-18bc9ecbe175.pdf",
            "news_date": "2024-08-08 12:06:08"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting Intimation To Consider And Approve The Un-Audited Financial Results For The Quarter Ended On June 30, 2024.",
            "news_body": "LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 ,inter alia, to consider and approve the un-audited financial results (standalone and consolidated) of the Company for the quarter ended on June 30, 2024 along with any other business, if any.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86312581-890d-49b2-999d-fda42e4b9275.pdf",
            "news_date": "2024-07-30 15:52:13"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Company Update",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018",
            "news_body": "We hereby submit the confirmation certificate as received from M/S Link Intime India Private Limited, Registrar and Share Transfer Agent for the Quarter Ended June 30, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c5a3534-b32c-4ebc-a258-4b5f1684af76.pdf",
            "news_date": "2024-07-06 14:49:55"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Closure of Trading Window for the Quarter ended June 30, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3079dee3-18ca-4d69-85a9-253127720313.pdf",
            "news_date": "2024-06-26 11:54:59"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Munjal Mahendrabhai Patel & PACs",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=C4EBF6AF_1456_4676_A9A3_023407DE3E4A_105922.pdf",
            "news_date": "2024-06-11 10:59:25"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Insider Trading / SAST",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Munjal Mahendrabhai Patel & PACs",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=D902B143_A306_48D3_BCF0_8BF63F2B0182_170554.pdf",
            "news_date": "2024-06-03 17:05:59"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Company Update",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Annual Secretarial Compliance Report for the Financial Year Ended March 31, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c7cb0d2-a553-4759-a7ad-7f73acfd3113.pdf",
            "news_date": "2024-05-24 18:26:47"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "AGM/EGM",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Outcome of Postal Ballot- Voting Results and Scrutinizer Report",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d57f3c7-cf0b-4050-a3a2-059216fc5206.pdf",
            "news_date": "2024-05-20 17:35:25"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "AGM/EGM",
            "descriptor": "Postal Ballot",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot",
            "news_body": "Outcome of Postal Ballot-Voting Results and Scrutinizer Report",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7be7613e-90dc-4aa1-a202-5e1b4f84844f.pdf",
            "news_date": "2024-05-20 17:32:01"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 , we attach herewith transcript of Conference Call held on May 16, 2024 . A copy of the same is available on the website of the Company.",
            "news_id": "c8ca6f60-29e4-497b-9863-50925fe451cb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08f8b461-6548-4a68-8a3d-f0456f03d61c.pdf",
            "news_date": "2024-05-18 17:12:31",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Company Update",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 , we attach herewith transcript of Conference Call held on May 16, 2024 . A copy of the same is available on the website of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08f8b461-6548-4a68-8a3d-f0456f03d61c.pdf",
            "news_date": "2024-05-18 17:12:31"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "We enclosed herewith the copies of published newspaper advertisement with respect to Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Year ended March 31, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=63f002d6-5e7d-4aea-bf64-503d32e4879e.pdf",
            "news_date": "2024-05-17 14:32:41"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Company Update",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "We wish to inform you that the Company participated in investor conference- Call Conference on May 16, 2024. No Unpublished Price Sensitive Information (UPSI) was shared / discussed in the meeting with investors.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=59d0d798-5ec9-4421-bfc2-fe4c19caa773.pdf",
            "news_date": "2024-05-16 20:41:45"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Company Update",
            "descriptor": "General",
            "caption": "FINANCIAL HIGHLIGHTS WITH RESPECT TO AUDITED FINANCIAL RESULTS FOR QUARTER AND YEAR ENDED MARCH 31, 2024",
            "news_body": "FINANCIAL HIGHLIGHTS WITH RESPECT TO AUDITED FINANCIAL RESULTS FOR QUARTER AND YEAR ENDED MARCH 31, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c218363-5c32-4c13-b842-23f3229bde79.pdf",
            "news_date": "2024-05-16 12:53:31"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Corp. Action",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board approves Dividend",
            "news_body": "Recommended a final Dividend of Rs.1.80/- (i.e.18%) per equity share of face value of Rs.10/- each for the financial year ended 31st March, 2024 for approval of the member at the ensuring AGM of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ebaf4eac-5d1e-4927-9d73-f3ad1f9b2e7b.pdf",
            "news_date": "2024-05-16 12:25:04"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For Quarter And Year Ended 31St March, 2024",
            "news_body": "Audited Financial Results for Quarter and year Ended 31st March,2024.",
            "news_id": "5b11816f-c827-4413-a732-8c88c58bdd73",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9049dd4-85a9-40d1-ab8e-23ef22c27b97.pdf",
            "news_date": "2024-05-16 12:14:59",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Result",
            "descriptor": "Financial Results",
            "caption": "Audited Financial Results For Quarter And Year Ended 31St March, 2024",
            "news_body": "Audited Financial Results for Quarter and year Ended 31st March,2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9049dd4-85a9-40d1-ab8e-23ef22c27b97.pdf",
            "news_date": "2024-05-16 12:14:59"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Board Meeting",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Audited Financial Results For Quarter And Year Ended On 31St March, 2024",
            "news_body": "outcome of Audited Financial Results for Quarter and year Ended on 31st March, 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0440d3cd-4ebf-4c82-861c-20b3944663a3.pdf",
            "news_date": "2024-05-16 12:07:15"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Company Update",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Copies of Newspaper Advertisement as required under Rule 6 of IEPF Authority (Accounting, Audit, Transfer and Refund) Rules, 2016 and amendments thereof,",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac610ee7-9916-4dc2-8aec-72676cf0cc9d.pdf",
            "news_date": "2024-05-15 12:41:12"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Company Update",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Q4 FY24 post results earning call details",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da771397-6d71-45c8-9906-c1e4f432cddb.pdf",
            "news_date": "2024-05-15 12:06:14"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Corp Action",
            "descriptor": "Dividend/AGM",
            "caption": "Corporate Action-Board to consider Dividend",
            "news_body": "Meeting of the Board of the Directors is scheduled to be held on May 16, 2024 to consider and approve Audited Financial Results of the Company and recommendation of Dividend on equity shares of the Company if any.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a1e3efb-aec9-42a1-a4c0-ca29f816ec8e.pdf",
            "news_date": "2024-05-08 17:18:43"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Board Meeting",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Of Board Meeting To Consider And Approve Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter And Year Ended On March 31, 2024.",
            "news_body": "LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2024 ,inter alia, to consider and approve Audited (standalone and consolidated) financial results of the Company for the quarter and year ended on March 31, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46a715c0-6357-420c-88c7-62b50581fc54.pdf",
            "news_date": "2024-05-08 17:09:01"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Company Update",
            "descriptor": "Reg. 40 (10) - PCS Certificate for Transfer / Transmission / Transposition",
            "caption": "Certificate Under Regulation 40 (9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "Please find enclosed herewith the Certificate from the Practicing Company Secretary under Regulation 40(9) of the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 for the year ended March 31, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=010987d3-ac15-4760-ad48-78750440293e.pdf",
            "news_date": "2024-04-22 15:31:32"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "",
            "descriptor": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure",
            "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
            "news_body": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>LINCOLN PHARMACEUTICALS LTD.</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24230GJ1995PLC024288</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table>  <br/><br/> <div> <div style=''float:left;''> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No</div> <br/><br/><br/> <div style=''float:left;''> Name of the Company Secretary: TRUSHA SHAH <br/>  Designation: COMPANY SECRETARY <br/> EmailId: trushashah@lincolnpharma.com</div> <div ''style=float:left;margin-left:50px;''> Name of the Chief Financial Officer: DARSHIT SHAH <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: darshit@lincolnpharma.com</div> </div> <div> <br/> Date: 18/04/2024<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b7c0dcf-a0b3-49fc-96cb-86412a0217ed.pdf",
            "news_date": "2024-04-18 11:01:36"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "",
            "descriptor": "Format of the Annual Disclosure to be made by an entity identified as a LC : Annexure B2",
            "caption": "Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2",
            "news_body": "<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''>    <tr>       <td><b>Sr. No.</b></td>       <td><b>Particulars</b></td>       <td><b>Details</b></td>    </tr>    <tr>       <td>1</td>       <td>Name of Company</td>       <td>LINCOLN PHARMACEUTICALS LTD.</td>    </tr>    <tr>       <td>2</td>       <td>CIN NO.</td>       <td>L24230GJ1995PLC024288</td>    </tr>    <tr>       <td>3</td>       <td>Report filed for FY</td>       <td>2023-2024</td>    </tr>       <tr><td colspan=''3''>Details of the Current block (all figures in Rs crore):</td><tr> <tr>       <td>4</td>       <td>2 - year block period (Specify financial years)* </td>       <td>2023-2024, 2024-2025</td>    </tr>    <tr>    <tr>       <td>5</td>       <td>Incremental borrowing done in FY (T)(a) </td>       <td>0.00</td>    </tr>    <tr>       <td>6</td>       <td>Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a)</td>       <td>0.00</td>    </tr>    <tr>       <td>7</td>       <td>Actual borrowing done through debt securities in FY (T)(c)</td>       <td>0.00</td>    </tr>       <tr>       <td>8</td>       <td> Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d)</td>       <td>0</td>    </tr>  <tr> <td>8</td><td>Quantum of (d), which has been met from (c)(e)*</td>       <td>0</td>    </tr><tr> <td>9</td><td> Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}*</td>       <td>0</td>    </tr> </table> <br/><br/><table><tr><td colspan=''2''><b>Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore):</b></td></tr> <tr><td>2 - year Block period (Specify financial years)</td><td>2023-2024, 2024-2025</td></tr> <tr><td>Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#</td><td>0.00</td></tr> </table> <div>     <br/><br/><br/>    <table><tr><td>Name of the Company Secretary :-</td><td>TRUSHA SHAH</td></tr><tr><td>Designation :-</td><td>COMPANY SECRETARY</td></tr>    <tr><td>Name of the Chief Financial Officer :- </td><td>DARSHIT SHAH</td></tr>    <tr><td>Designation : -</td><td>CHIEF FINANCIAL OFFICER</td></tr></table><div> <br/> Date: 17/04/2024<br/><br/></div>",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b42f2773-0b38-4819-88ab-3ce9617bca50.pdf",
            "news_date": "2024-04-17 18:08:57"
        },
        {
            "co_code": 12683,
            "bse_code": 531633,
            "isin": "INE405C01035",
            "ann_type": "Company Update",
            "descriptor": "Reg. 7(3) \u2013 Compliance Certificate (RTA & Compliance Officer)",
            "caption": "Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Year Ended March 31, 2024.",
            "news_body": "Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015 for the year ended March 31, 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52967872-f0f0-46a6-a193-4ce584358dca.pdf",
            "news_date": "2024-04-15 11:03:15"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results Of The Company<BR> <BR>",
            "news_body": "Considered and approved un-audited financial results (standalone and consolidated) of the Company along with limited review reports for the Quarter and Nine Months ended on December 31, 2023.",
            "news_id": "75f7052b-f969-4148-8089-affa1aac7f68",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d512ae99-cea7-487f-89c6-fb236805ee45.pdf",
            "news_date": "2024-02-08 12:28:43",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for OUTCOME OF THE BOARD MEETING",
            "news_body": "OUTCOME OF THE BOARD MEETING",
            "news_id": "924993dc-2e89-4150-8c2e-91b45a211d94",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a734abf-ace5-4415-b774-3487bc1bb28e.pdf",
            "news_date": "2024-02-08 12:22:43",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For Quarter And Half Year Ended On 30.09.2023",
            "news_body": "Un-Audited Financial Results for Quarter and Half year ended on 30.09.2023",
            "news_id": "805c0dea-2324-40d3-b890-bfc5988fb09a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2f6cae7-a7ec-4e61-9d56-5925179152cb.pdf",
            "news_date": "2023-11-02 12:24:29",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Un-Audited Financial Results for the Quarter and half year ended 30.09.2023",
            "news_id": "48d54030-6190-4bde-81e8-ae20a60fd26c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=21ed9d5f-4d9d-4610-b9b1-2be0d2097bf0.pdf",
            "news_date": "2023-11-02 12:20:30",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone & Consolidated Financial Results Of The Company For The Quarter Ended 30.06.2023.",
            "news_body": "Unaudited Standalone & Consolidated Financial Results of the Company for the Quarter ended 30.06.2023",
            "news_id": "36f48dac-8b82-4fd8-bda0-7690e37b9adf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6fa011d6-f470-45a5-a896-f31780213341.pdf",
            "news_date": "2023-08-10 12:22:23",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "FINANCIAL RESULTS (STANDALONE AND CONSOLIDATED) FOR THE QUARTER AND YEAR ENDED 31.03.2023",
            "news_body": "FINANCIAL RESULTS (STANDALONE AND CONSOLIDATED) FOR THE QUARTER AND YEAR ENDED 31.03.2023",
            "news_id": "ca0cfc97-40b1-453e-8ccf-f0dc5acd12d6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50d401bd-be28-48a2-8497-4ff77a061264.pdf",
            "news_date": "2023-05-25 11:42:47",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Financial Results (Standalone And Consolidated) For The Quarter And Year Ended March 31, 2023",
            "news_body": "Financial Results (standalone and consolidated) for the Quarter and Year Ended March 31, 2023",
            "news_id": "3b21ee8f-4e00-440c-9de9-53f888a758ee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e6280846-0d2c-4011-b8ad-1f08388f13be.pdf",
            "news_date": "2023-05-25 11:37:58",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results Of The Company<BR>",
            "news_body": "To Consider and approved un-audited financial results (Standalone and Consolidated) of the Company along with the limited review reports for the quarter and nine months ended on December 31, 2022. <BR>",
            "news_id": "1ab38f4b-e747-44f4-b0e9-27650f74d1ec",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0608f114-16be-4307-b2ee-5a98ce7271c5.pdf",
            "news_date": "2023-02-09 12:55:56",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for OUTCOME OF BOARD MEETING<BR>",
            "news_body": "Outcome of the Board Meeting held today",
            "news_id": "ef7396fb-41e1-42b3-869b-78b15aab4283",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b322aa59-25e6-4da5-821c-5bf84de305a4.pdf",
            "news_date": "2023-02-09 12:51:39",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "Disclosure of Related Party Transactions pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
            "news_id": "97db2e09-0cff-495d-8fcf-aeb3323a2389",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f55b3bc-73e3-4967-a297-4f2a759cc77f.pdf",
            "news_date": "2022-11-24 15:30:22",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended On 30.09.2022",
            "news_body": "Unaudited Standalone and Consolidated Financial Results for the Quarter and Half Year ended on 30.09.2022<BR>",
            "news_id": "13e8951f-ec90-4725-ba07-c7d2425c1be8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cc6bda25-f17e-43ff-bcc4-9b13945ba8cc.pdf",
            "news_date": "2022-11-10 11:28:15",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "FINANCIAL RESULTS FOR QUARTER ENDED 30.06.22",
            "news_body": "FINANCIAL RESULTS FOR QUARTER ENDED 30.06.22",
            "news_id": "1a944a33-ac08-47a1-af93-86e0f78465a0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a3c737b-d56d-4d09-bdfa-7d521d84952a.pdf",
            "news_date": "2022-08-09 13:29:19",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Regulation 23(9)-Disclosure Of Related Party Transactions",
            "news_body": "In compliance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosure of related party transactions in the specified format for the half year ended March 31, 2022. The same available on the website of the Company at www.lincolnpharma.com",
            "news_id": "8a89af95-955b-42f5-8e34-573d79e6e737",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90129449-ace7-4f67-8c28-08ee0360239b.pdf",
            "news_date": "2022-06-02 11:40:24",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Result For The Quarter And Year Ended March 31, 2022",
            "news_body": "board consider audited financial result (standalone & consolidated) for the quarter and year ended March 31, 2022.",
            "news_id": "8cc77fe0-de7d-45dd-b364-8c7fc6de6451",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a89c535c-95e1-45d0-bb2f-962f61238623.pdf",
            "news_date": "2022-05-19 13:10:40",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Outcome of the Board Meeting",
            "news_id": "d1192d92-ffef-4671-b788-4719ed242a55",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e60f4779-504b-4f2f-9631-d9d018bec341.pdf",
            "news_date": "2022-05-19 12:49:02",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results Of The Company",
            "news_body": "To Consider and approved un-audited financial results (Standalone and Consolidated) of the Company along with the limited review reports for the quarter and nine months ended on December 31, 2021.",
            "news_id": "8cf4d91c-c971-4029-bbac-e43d71dd0267",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7bb9a00-d7e3-4531-8048-8ad3406f3cf8.pdf",
            "news_date": "2022-02-10 13:02:11",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended On September 30, 2021",
            "news_body": "Pursuant to Regulation 33 of the SEBI (LODR) Regulations, 2015, we would like to inform that the Board of Directors of the Company at its meeting held today i.e. Thursday, November 11, 2021, have considered and approved the un-audited financial results (Standalone and Consolidated) of the Company along with the limited review reports for the quarter and half year ended on September 30, 2021. Further, we enclose herewith financial highlights of the Company for the aforesaid quarter.",
            "news_id": "a05fc0d4-1793-47fa-8b49-12ace2e39033",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=91d18558-aa8e-4763-b1d8-2e6ea07a4baa.pdf",
            "news_date": "2021-11-11 12:54:41",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "Pursuant to Regulation 33 of the SEBI (LODR) Regulations, 2015, we would like to inform that the Board of Directors of the Company at its meeting held today i.e. Thursday, November 11, 2021, have considered and approved the un-audited financial results (Standalone and Consolidated) of the Company along with the limited review reports for the quarter and half year ended on September 30, 2021. Further, we enclose herewith financial highlights of the Company for the aforesaid quarter.",
            "news_id": "8a181142-d068-4716-bc8d-7fd28d7aa4e4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27b58009-134c-4e86-8449-1fddbbfe8a83.pdf",
            "news_date": "2021-11-11 12:51:05",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Result For The Quarter Ended June 30, 2021",
            "news_body": "We would like to inform that the Board of Directors of the Company at its meeting held today i.e. Tuesday, August 10, 2021, have considered and approved the un-audited financial results of the Company (Standalone and Consolidated) along with the limited review report for the quarter ended on June 30, 2021. Further, we enclose herewith financial highlights of the Company for the aforesaid quarter.",
            "news_id": "b79e3229-3b66-4882-8962-bb4117c3360b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=28524dbb-a447-4266-a19f-56bb38030323.pdf",
            "news_date": "2021-08-10 12:40:00",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting",
            "news_body": "We would like to inform that the Board of Directors of the Company at its meeting held today i.e. Tuesday, August 10, 2021, have considered and approved the un-audited financial results of the Company (Standalone and Consolidated) along with the limited review report for the quarter ended on June 30, 2021. Further, we enclose herewith financial highlights of the Company for the aforesaid quarter.",
            "news_id": "defa1f40-8371-43bc-b637-c6fda2032c15",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e518e0c-af61-4569-ba3f-a9c54317de62.pdf",
            "news_date": "2021-08-10 12:36:41",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Regulation 23 (9) - Disclosure Of Related Party Transaction For The Half Year Ended On March 31, 2021",
            "news_body": "Pursuant to Regulation 23 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the disclosure of Related Party Transactions on a consolidated basis, in the format specified in the relevant Indian accounting standards for the half year ended March 31, 2021.",
            "news_id": "1bd81328-363f-405e-a2d1-12d3d8181784",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4517edd3-1bc8-4511-8a58-f2454a686a13.pdf",
            "news_date": "2021-06-18 12:42:10",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "LINCOLN",
            "disp": "Lincoln Pharmaceuticals",
            "bse_code": 531633,
            "isin": "INE405C01035",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Result For The Quarter And Year Ended March 31, 2021",
            "news_body": "we would like to inform that the Board of Directors of the Company at its meeting held today i.e. Tuesday, May 25, 2021, have considered / approved / recommended, inter alia, the followings: (1) audited financial results (standalone and consolidated) for the quarter and year ended<BR> on March 31, 2021 along with the reports of auditors thereon. Recommended a dividend qf ~ 1.50/- (i.e. 15% per share) per equity share of face value of ~ 10.00/- for<BR> the year ended March 31, 2021, for approval of the members at the ensuring Annual General Meeting<BR> (AGM) of the Company. We also enclose herewith financial highlights of the Company for the aforesaid quarter.",
            "news_id": "33e4d390-3e6a-415d-b4ce-b714e131051c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7cfd01ee-55fb-4063-8875-915cdc19c967.pdf",
            "news_date": "2021-05-25 12:55:41",
            "seo": "lincoln-pharmaceuticals-ltd",
            "ltp": 528.85,
            "ch": -6.2999999999999545,
            "pch": -1.177240026160881,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 11596,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}